- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/08 - Antibacterial agents for leprosy
Patent holdings for IPC class A61P 31/08
Total number of patents in this class: 97
10-year publication summary
|
6
|
12
|
4
|
4
|
0
|
7
|
5
|
2
|
4
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
5 |
| Janssen Pharmaceutica N.V. | 3147 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 784 |
4 |
| I-mab Biopharma Co., Ltd. | 50 |
3 |
| Merck Sharp & Dohme LLC | 3733 |
3 |
| Novartis AG | 10169 |
2 |
| Sumitomo Chemical Company, Limited | 8965 |
2 |
| Colorado State University Research Foundation | 725 |
2 |
| Denovamed Inc. | 11 |
2 |
| Procomcure Biotech GmbH | 27 |
2 |
| Sekisui Chemical Co., Ltd. | 3639 |
2 |
| Sekisui Polymatech Co., Ltd. | 217 |
2 |
| Arvinas Operations, Inc. | 248 |
2 |
| Novartis Pharma AG | 277 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| AstraZeneca AB | 2823 |
1 |
| Pfizer Inc. | 3418 |
1 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 312 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6711 |
1 |
| Board of Regents, The University of Texas System | 6172 |
1 |
| Other owners | 54 |